$PRVCF's CEO joined Steve Darling in the Vancouver studio of Proactive Investors to talk about the companies recent news that they had successfully optimized the conditions for extracting cannabinoids from one of its cannabis strains and developed a proprietary method for the accurate measurement of cannabinoids. He also shared details of their duel gene therapy program that deals with diabetes and obesity. Learn more about PreveCeutical Medical, Inc. at: https://www.preveceutical.com



https://youtu.be/Wh9megh8d4A